InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 937

Tuesday, 04/08/2008 5:22:15 AM

Tuesday, April 08, 2008 5:22:15 AM

Post# of 1367
Kamada was granted new (in addition to congenital emphysema and CF) Orphan drug designation by the FDA, for its inhaled AAT for the treatment of Bronchiectasis (currently undergoing Phase II clinical trials).

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.